Now ideas for wellness

About Meiji

At a Glance

At a Glance

Get to know Meiji at a glance – from our core business to our most important numbers.

Pharmaceuticals

R&D

Medical needs are always diversifying – here's how Meiji is responding.

Invest in Meiji

The combined strengths of our food and pharmaceutical businesses, plus an emphasis on sustainability, help Meiji deliver long-term growth and stakeholder returns.

Products with the highest market shares in Japan

    • Yogurt
    • No.1
    • 38.6%
    • Market scale 458.8 billion yen
    • *1
    • Chocolate
    • No.1
    • 24.8%
    • Market scale 413.7 billion yen
    • *1
    • Cheese
    • No.3
    • 10.7%
    • Market scale 203.3 billion yen
    • *1
    • Powdered & granulated protein
    • No.1
    • 34.3%
    • Market scale 63.5 billion yen
    • *2
    • Systemic antibacterial drugs
    • No.1
    • 19.4%
    • Market scale 148.5 billion yen
    • *3
    • Influenza HA Vaccine
    • No.1
    • 35.5%
    • Market scale 76.9 billion yen
    • *3
Source:
  1. April 2021-March 2022, INTAGE SRI+, Market Share in value, Cumulative Sales
  2. Based on Meiji data as of March 2022
  3. Copyright © 2022 IQVIA.
    Calculated based on JPM 2022 Mar MAT
    Market scope as defined by Meiji Seika Pharma
    Reprinted with permission

Food and pharmaceuticals: strength in synergy

Meiji contributes to health and wellness across a number of market categories including food, nutritional products, and pharmaceuticals. Not only does this give us a broad portfolio, we're able to leverage these different strengths into integrated R&D that creates new health value for consumers and society.

Co-Creation Center
Co-Creation Center

LEARN MORE

Main areas of business

Food
Food
  • Yogurt & cheese
  • Nutrition
  • Chocolate & gummy
  • Drinking milk
  • Business-to-Business
  • Frozen dessert & ready meal
  • Overseas
  • Other / domestic subsidiaries
Pharmaceuticals
Pharmaceuticals
  • Domestic ethical pharmaceuticals
  • Overseas ethical pharmaceuticals
  • Human vaccines
  • Veterinary drugs
Graph: Net sales ratio by segment (FY2022)

Net sales ratio by segment (FYE 3/2022)

  • Food Business
  • 81.0%
  • 826.0 billion yen
  • Pharmaceutical Business
  • 19.0%
  • 187.9 billion yen
Graph: Net sales ratio by segment (FY2022)

Net sales ratio by region (FYE 3/2022)

  • Japan
  • 90.8%
  • 920.1 billion yen
  • Overseas
  • 9.2%
  • 92.9 billion yen

Sustainability: a healthier society

Meiji is committed to fulfilling its environmental and social responsibilities. As professionals in food and health, we're uniquely able to contribute to the health and wellness of individuals, which in turn leads to a healthier society and planet. Our environmental and social policies and performance are regularly updated on our main Sustainability page.

Photho:Sustainable Management
Sustainability Management
LEARN MORE

Improved performance and dividends

The Meiji Group has achieved long-term stable growth and shareholder returns through the sales expansion of core businesses.

Net sales
Graph:Net sales

From FYE 3/2022, net sales show the figures after applying revenue recognition accounting standards.

Return on equity (ROE)
Graph:Return on equity (ROE)
EBITDA
Graph:EBITDA
Payout ratio
Graph:Payout ratio

DATA BOOK FY2021 - From April 1, 2021 to March 31, 2022 - (PDF 1645KB)

Photo:New slogan
Group Slogan
LEARN MORE
Photo:Business Plans
Business Plans
LEARN MORE
Photo:Year in Review
Year in Review
LEARN MORE